Interactive Investor

Woodford sells stake in trust as board considers dropping him

Neil Woodford sells over half his stake in Woodford Patient Capital Trust and may be sacked as manager.

29th July 2019 16:39

by Tom Bailey from interactive investor

Share on

Neil Woodford has sold over half of his stake in Woodford Patient Capital Trust as speculation grows that he may be sacked as manager of the trust.

Neil Woodford has sold over half of his stake in Woodford Patient Capital Trust (LSE:WPCT), as speculation grows that he may be dropped as manager.

The board of the trust has announced that it has been in talks with "select management groups" recently to discuss future management of the trust.

The trust noted it would "engage with a broader range of third-party managers...which may or may not lead to a change in the company's management arrangements".

Separately, the board announced  that Woodford has sold 60% of his stake in WPCT. Woodford sold 1,750,000 shares between in the first week of July, with shares trading at between 58p and 56.6p. The sale was justified on the grounds that the cash was needed by Woodford for personal financial obligations including a tax bill.

Numis Securities noted in response: "We are surprised that Neil Woodford needed to sell WPCT shares to generate liquidity of c.£1 million (Woodford IM paid £36.5 million of dividends to its shareholders in FY18). Despite the explanation provided, his sale of WPCT not something that is likely to be viewed positively by shareholders, in our view."

Source: TradingView Past performance is not a guide to future performance

Speculation that Woodford could lose control of this namesake trust comes two months after he was forced to suspend trading in the open-ended LF Woodford Equity Income fund.

The fund's suspension and the subsequent fallout has tarnished Woodford's reputation, with the manager losing his mandate for various other funds he managed, while WPCT's share price suffered. The trust now sits on a discount of 34%.   

In particular, Woodford came under heavy criticism for the way he managed the fund. At the same time, the cross-over between Woodford Patient Capital and Woodford Equity Income has raised fears that the former's performance could further suffer. 

Woodford has also come under criticism for his company's decision to continue charging a management fee for the income fund. However, Woodford does not a charge a management fee for WPCT, and recently announced that he would forego his own salary while the open-ended fund is in suspension.

Not all investors have lost faith in Woodford. As data from interactive investor recently showed, WPCT was the most purchased trust in June, with the number of buys nearly double those of Scottish Mortgage (LSE:SMT).

Many investors are likely to be betting on Woodford being able to improve performance and recover his reputation (as he has before). Others, however, may be holding out hope that the board moves to choose a new manager.

And there was further pain for investors in the LF Woodford Equity Income today after the fund's authorised corporate director, Link Fund Solutions (LFS), said suspension of investor dealing is likely to last until early December. 

"The decision to continue with the suspension of the fund is to ensure investors' interests are protected," LFS said in a statement this afternoon. "It affords Neil and the team the required time to execute the changes to the portfolio that we have outlined previously, in order to deliver the best possible outcomes for you, our investors."

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

This article was originally published in our sister magazine Money Observer, which ceased publication in August 2020.

These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

Get more news and expert articles direct to your inbox